Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» China Biotech In Review: GSK's Q4 China Revenues Actually Point To Recovery
China Biotech In Review: GSK's Q4 China Revenues Actually Point To Recovery
China Biotech In Review: GSK's Q4 China Revenues Actually Point To Recovery
Submitted by
admin
on February 10, 2014 - 8:30am
Source:
Seeking Alpha
News Tags:
China
GSK
Abiomed
Sagent Pharmaceuticals
Headline:
China Biotech In Review: GSK's Q4 China Revenues Actually Point To Recovery
Do Not Allow Advertisers to Use My Personal information
